Farringdon Capital’s Labcorp LH Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$582K Buy
+2,180
New +$590K 0.13% 207
2025
Q4
Sell
-1,013
Closed -$291K 553
2025
Q3
$291K Buy
+1,013
New +$271K 0.07% 332
2025
Q2
Sell
-4,227
Closed -$984K 525
2025
Q1
$984K Buy
+4,227
New +$1.03M 0.5% 38

Other funds holding LH

Farringdon Capital's LH Position: Q1 2026 in Review

Farringdon Capital opened a new position in Labcorp (LH) in Q1 2026: 2,180 shares worth $582K. The stake represents 0.13% of the portfolio and ranks #207 among its holdings. This is a return to the name: Farringdon Capital previously reported a position in LH as recently as Q3 2025.

Farringdon Capital first reported a position in LH in Q1 2025 and has held it in 3 quarters since. The position peaked at $984K in Q1 2025. 1,032 funds tracked by Wall St. Rank hold LH as of Q1 2026.

  • Farringdon Capital held 2,180 shares of Labcorp worth $582K as of Q1 2026.
  • Labcorp was a new Farringdon Capital position in Q1 2026.
  • Labcorp made up 0.13% of Farringdon Capital's portfolio in Q1 2026, its #207 holding.
  • Farringdon Capital first reported a position in Labcorp in Q1 2025 and has held it in 3 quarters since.
  • Farringdon Capital's Labcorp position peaked at $984K in Q1 2025.
  • 1,032 funds tracked by Wall St. Rank held Labcorp as of Q1 2026.

Based on Farringdon Capital's 13F filing for Q1 2026, filed 15 May 2026.